|
|
|
Volumn 86, Issue 4, 2001, Pages 253-268
|
|
Adjuvant and neoadjuvant chemotherapy in osteosarcoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CISPLATIN;
DOXORUBICIN;
IFOSFAMIDE;
METHOTREXATE;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
AMPUTATION;
BONE TUMOR;
CHILD;
CLASSIFICATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FOLLOW UP;
HUMAN;
LIMB;
METASTASIS;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
OSTEOSARCOMA;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TIME;
AMPUTATION;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
BONE NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CHILD;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
DOXORUBICIN;
EXTREMITIES;
FOLLOW-UP STUDIES;
HUMANS;
IFOSFAMIDE;
METHOTREXATE;
MULTICENTER STUDIES;
NEOADJUVANT THERAPY;
NEOPLASM METASTASIS;
OSTEOSARCOMA;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TIME FACTORS;
|
|
EID: 0035496579
PISSN: 00094749
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (42)
|
